ATE200663T1 - 17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon - Google Patents

17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon

Info

Publication number
ATE200663T1
ATE200663T1 AT96943236T AT96943236T ATE200663T1 AT E200663 T1 ATE200663 T1 AT E200663T1 AT 96943236 T AT96943236 T AT 96943236T AT 96943236 T AT96943236 T AT 96943236T AT E200663 T1 ATE200663 T1 AT E200663T1
Authority
AT
Austria
Prior art keywords
derivatives
oxopregna
alknyl
vitamin
production
Prior art date
Application number
AT96943236T
Other languages
English (en)
Inventor
Robert Henry Hesse
Maurice Murdoch Pechet
Sundara Katugam Srinivas Setty
Original Assignee
Res Inst Medicine Chem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Inst Medicine Chem filed Critical Res Inst Medicine Chem
Application granted granted Critical
Publication of ATE200663T1 publication Critical patent/ATE200663T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT96943236T 1995-12-21 1996-12-23 17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon ATE200663T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9526208.5A GB9526208D0 (en) 1995-12-21 1995-12-21 Chemical compounds
PCT/GB1996/003218 WO1997023453A1 (en) 1995-12-21 1996-12-23 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
ATE200663T1 true ATE200663T1 (de) 2001-05-15

Family

ID=10785847

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96943236T ATE200663T1 (de) 1995-12-21 1996-12-23 17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon

Country Status (21)

Country Link
US (2) US6372926B2 (de)
EP (1) EP0874815B1 (de)
JP (1) JP2000503636A (de)
KR (1) KR19990076664A (de)
CN (1) CN1086694C (de)
AT (1) ATE200663T1 (de)
AU (1) AU710680B2 (de)
CA (1) CA2241011A1 (de)
CZ (1) CZ290930B6 (de)
DE (1) DE69612568T2 (de)
DK (1) DK0874815T3 (de)
ES (1) ES2155948T3 (de)
GB (1) GB9526208D0 (de)
GR (1) GR3036132T3 (de)
HU (1) HUP9903786A3 (de)
IL (1) IL125027A0 (de)
NO (1) NO982816L (de)
NZ (1) NZ324775A (de)
PT (1) PT874815E (de)
WO (1) WO1997023453A1 (de)
ZA (1) ZA9610874B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481909C (en) * 2002-04-11 2013-07-02 Instytut Farmaceutyczny Preparation of 24-alkyl analogs of cholecalciferol
WO2005067673A2 (en) * 2004-01-06 2005-07-28 The University Of Tennessee Research Foundation Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof
US20110104186A1 (en) 2004-06-24 2011-05-05 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
WO2006100285A1 (en) * 2005-03-23 2006-09-28 Bioxell Spa Use of vitamin d compounds to treat endometriosis
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs
SG2014006324A (en) * 2009-01-27 2014-03-28 Berg Llc Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy
CN102655869B (zh) 2009-08-14 2016-08-10 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
JP5563324B2 (ja) * 2010-02-03 2014-07-30 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトール中間体およびその製造方法
HK1222819A1 (zh) 2013-05-29 2017-07-14 博格有限责任公司 使用维生素d预防或减轻化疗诱发的脱发

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034543B2 (ja) 1977-07-01 1985-08-09 中外製薬株式会社 ビタミンd誘導体
GB9214202D0 (en) 1992-07-03 1992-08-12 Leo Pharm Prod Ltd Chemical compounds
GB9220439D0 (en) 1992-09-28 1992-11-11 Leo Pharm Prod Ltd Chemical compounds
US5397776A (en) 1993-08-20 1995-03-14 Wisconsin Alumni Research Foundation Vitamin D compounds with anti-progesterone activity

Also Published As

Publication number Publication date
EP0874815A1 (de) 1998-11-04
NO982816D0 (no) 1998-06-18
US20020010163A1 (en) 2002-01-24
GR3036132T3 (en) 2001-09-28
DE69612568D1 (de) 2001-05-23
IL125027A0 (en) 1999-01-26
GB9526208D0 (en) 1996-02-21
CA2241011A1 (en) 1997-07-03
US20020188142A1 (en) 2002-12-12
JP2000503636A (ja) 2000-03-28
DE69612568T2 (de) 2001-09-06
CZ290930B6 (cs) 2002-11-13
CN1086694C (zh) 2002-06-26
WO1997023453A1 (en) 1997-07-03
ES2155948T3 (es) 2001-06-01
NZ324775A (en) 1999-02-25
HUP9903786A2 (hu) 2000-03-28
CZ194798A3 (cs) 1998-11-11
PT874815E (pt) 2001-07-31
NO982816L (no) 1998-08-21
US6372926B2 (en) 2002-04-16
ZA9610874B (en) 1997-06-18
DK0874815T3 (da) 2002-03-04
CN1209120A (zh) 1999-02-24
KR19990076664A (ko) 1999-10-15
AU710680B2 (en) 1999-09-30
HUP9903786A3 (en) 2000-09-28
AU1202597A (en) 1997-07-17
EP0874815B1 (de) 2001-04-18

Similar Documents

Publication Publication Date Title
ES2108371T3 (es) Nuevos derivados de estradieno de 11-benzaldoxima, procedimientos para su produccion y farmacos conteniendo estos compuestos.
ATE145649T1 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta- 5alpha-androstane, androstene und androstadiene, ein verfahren zu ihrer herstellung und pharmazeutische präperate davon
DK0982032T3 (da) Anvendelse af en sulfamatesterholdig sterolforbindelse til fremstilling af et lægemiddel til kontrol af østrogenproduktion
PT831837E (pt) Utilizacao de esqualamina no fabrico de um medicamento para inibicao de nhe
WO2003062259A3 (en) Non-aromatic 17.alpha.-esters of androstane-17.beta.-carboxylate esters as anti-inflammatory agents
ES2158327T3 (es) Derivados de benzo(g)quinolina.
ATE153022T1 (de) 3',5'-ditertbutyl-4'-hydroxyflavone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung mit antioxidations- und antivasokonstriktionsaktivität
ATE302778T1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE368050T1 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
DE69103089D1 (de) Alicyclische Verbindung enthaltende Komposition, Verfahren für ihre Herstellung, polymerisierbare Komposition und photopolymerisierbare Komposition.
DE69612568D1 (de) 17-seitenkette-alknyl- und 20-oxopregna-derivate von vitamin d, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
EP1132379A4 (de) Thiolderivate, verfahren zu ihrer herstellung und ihre anwendung
ATE152118T1 (de) Kardioaktive 17b-(3-furyl) und 17b-(4- pyridazinyl)-5beta, 14beta-androstan derivate, verfahren zu ihrer herstellung und pharmazeutische präparate davon
ES2160308T3 (es) Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2182090T3 (es) Nuevos derivados de pirrol.
ATE401303T1 (de) Verfahren zur herstellung von ed-71
DE58900439D1 (de) N-substituierte-n-nitroso-aminoacetonitrile, verfahren zu ihrer herstellung und ihre verwendung.
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE69609201D1 (de) 21-[2-oxo-tetrahydrofuran]-thio pregnan derivative, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
NO20022896D0 (no) Substituerte 1- og 2-naftol mannich baser
IT1269584B (it) Procedimento per la preparazione di derivati di 5,6-diidrossi- 2-ammino-1,2,3,4- tetraidronaftalene
DK0820435T3 (da) Fremgangsmåde til fremstilling af i det væsentlige rene isomerer af alpha-bisoximer
ATE195529T1 (de) 17beta-(2-oxo-tetrahydrofuran-4-yl)-thio- androstane derivate (17beta-(gamma-buttersäure- lacton)-thio derivate) zur behandlung von entzündungen, pharmazeutische präparate davon und ein verfahren zu ihrer herstellung
AR003967A1 (es) Epimeros de (22r)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-oxo-4-aza-5alfa- androst-1-eno-17beta-carboxamida, un proceso para su preparacion y unacomposicion farmaceutica que los comprenden.
ATE73455T1 (de) 4,4-dimethyltetrahydropyr-2-on-derivate, verfahren zu ihrer herstellung und ihre verwendung zur synthese von pyretrinverbindungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee